SMMT - サミット・セラピュ―ティクス (Summit Therapeutics plc)

SMMTのニュース

   Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster  2021/07/01 12:00:00 Intrado Digital Media
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the Company) today announced that members of our scientific team will present breakthrough research updates at the 31 st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will be held virtually July 9 12. Our three posters to be presented are as follows, one of which was designated as a Top Rated ePoster by the ECCMID conference:
   Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator  2021/06/22 17:25:45 Seeking Alpha
   Summit Therapeutics to join Russell 3000 Index  2021/06/08 11:35:24 Seeking Alpha
   Summit Therapeutics set to join Russell 3000 Index  2021/06/08 11:00:00 Wallstreet:Online
Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to a preliminary list of additions posted by FTSE Russell. Annual Russell indexes reconstitution captures the 4,000 largest US stocks
   Summit Therapeutics set to join Russell 3000® Index  2021/06/08 00:00:00 BioSpace
Summit Therapeutics Inc. is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to a preliminary list of additions posted by FTSE Russell.
   SUMMIT THERAPEU/S (NASDAQ:SMMT) Stock Crosses Above 50-Day Moving Average of $3.41  2020/10/20 01:00:49 Daily Political
SUMMIT THERAPEU/S (NASDAQ:SMMT) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.41 and traded as high as $3.61. SUMMIT THERAPEU/S shares last traded at $3.47, with a volume of 60,582 shares. Separately, Zacks Investment Research cut SUMMIT THERAPEU/S from a “hold” […]
   Summit Therapeutics files for $200M mixed shelf (NASDAQ:SMMT)  2020/10/06 09:46:48 Seeking Alpha
Summit Therapeutics (NASDAQ:SMMT) has filed a prospectus for a $200M mixed shelf offering.
   Summit Therapeutics PLC (SMMT) Outpaces Stock Market Gains: What You Should Know  2020/05/27 21:45:15 Zacks Investment Research
Summit Therapeutics PLC (SMMT) closed at $4.20 in the latest trading session, marking a +1.94% move from the prior day.
   Summit Therapeutics PLC (SMMT) Stock Moves -0.43%: What You Should Know  2020/05/19 21:45:13 Zacks Investment Research
In the latest trading session, Summit Therapeutics PLC (SMMT) closed at $3.48, marking a -0.43% move from the previous day.
   Is Summit Therapeutics (SMMT) Outperforming Other Medical Stocks This Year?  2020/05/13 15:30:09 Zacks Investment Research
Is (SMMT) Outperforming Other Medical Stocks This Year?
   SUMMIT THERAPEU/S (NASDAQ:SMMT) Stock Crosses Above 50-Day Moving Average of $3.41  2020/10/20 01:00:49 Daily Political
SUMMIT THERAPEU/S (NASDAQ:SMMT) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.41 and traded as high as $3.61. SUMMIT THERAPEU/S shares last traded at $3.47, with a volume of 60,582 shares. Separately, Zacks Investment Research cut SUMMIT THERAPEU/S from a “hold” […]
   Summit Therapeutics files for $200M mixed shelf (NASDAQ:SMMT)  2020/10/06 09:46:48 Seeking Alpha
Summit Therapeutics (NASDAQ:SMMT) has filed a prospectus for a $200M mixed shelf offering.
   Summit Therapeutics PLC (SMMT) Outpaces Stock Market Gains: What You Should Know  2020/05/27 21:45:15 Zacks Investment Research
Summit Therapeutics PLC (SMMT) closed at $4.20 in the latest trading session, marking a +1.94% move from the prior day.
   Summit Therapeutics PLC (SMMT) Stock Moves -0.43%: What You Should Know  2020/05/19 21:45:13 Zacks Investment Research
In the latest trading session, Summit Therapeutics PLC (SMMT) closed at $3.48, marking a -0.43% move from the previous day.
   Is Summit Therapeutics (SMMT) Outperforming Other Medical Stocks This Year?  2020/05/13 15:30:09 Zacks Investment Research
Is (SMMT) Outperforming Other Medical Stocks This Year?

calendar